Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study
Artificial Organs · 2024
DOI: 10.1111/aor.14708 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Artificial Organs, 2024. Verfasst von Roberto Rordorf und 17 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia and Electrophysiology Unit, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Heart Failure, Heart-Assist Devices, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Left ventricular assist device (L‐VAD) implantation is increasingly used in patients with heart failure (HF) and most patients also have an implantable cardioverter defibrillator (ICD). Limited data are available on the incidence of ICD therapies and complications in this special setting. The aim of this study was to analyze the real‐world incidence and predictors of ICD therapies, complications and interactions between ICD and L‐VAD.
Methods
We conducted a multicenter retrospective observational study in patients with advanced HF implanted with ICD and a continuous‐flow L‐VAD, followed‐up in five advanced HF centers in Northern Italy.
Results
A total of 234 patients (89.7% male, median age 59, 48.3% with ischemic etiology) were enrolled. After a median follow‐up of 21 months, 66 patients (28.2%) experienced an appropriate ICD therapy, 22 patients (9.4%) an inappropriate ICD therapy, and 17 patients (7.3%) suffered from an interaction between ICD and L‐VAD. The composite outcome of all ICD‐related complications was reported in 41 patients (17.5%), and 121 (51.7%) experienced an L‐VAD‐related complication. At multivariable analysis, an active ventricular tachycardia (VT) zone and a prior ICD generator replacement were independent predictors of ICD therapies and of total ICD‐related complications, respectively.
Conclusions
Real‐world patients with both L‐VAD and ICD experience a high rate of ICD therapies and complications. Our findings suggest the importance of tailoring device programming in order to minimize the incidence of unnecessary ICD therapies, thus sparing the need for ICD generator replacement, a procedure associated to a high risk of complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arrhythmia and Electrophysiology Unit, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
- De Gasperis CardioCenter, Niguarda Hospital, Milan, Italy.
- Division of Cardiology, IRCCS Policlinico S. Matteo, Pavia, Italy.
- Division Cardiac Surgery, IRCCS Policlinico S. Matteo, Pavia, Italy.
- Department of Perioperative Cardiology and Cardiovascular imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
ORCID-Profile: Roberto Rordorf, Matteo Casula, Francesco Cannata
Zitieren
APA
Rordorf, R., Pignalosa, L., Casula, M., Perna, E., Baroni, M., Garascia, A., Guida, S., Gazzoli, F., Pini, D., Cannata, F., Pellegrino, M., Vittori, C., De Filippo, P., Malanchini, G., Vergara, P., Della Bella, P., Gulletta, S., & all the Investigators of the study (2024). Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study. Artificial Organs. https://doi.org/10.1111/aor.14708
Vancouver
Rordorf R, Pignalosa L, Casula M, Perna E, Baroni M, Garascia A, et al. Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study. Artificial Organs. 2024. doi:10.1111/aor.14708
BibTeX
@article{Rordorf2024,
author = {Rordorf, Roberto and Pignalosa, Leonardo and Casula, Matteo and Perna, Enrico and Baroni, Matteo and Garascia, Andrea and Guida, Stefania and Gazzoli, Fabrizio and Pini, Daniela and Cannata, Francesco and Pellegrino, Marta and Vittori, Claudia and De Filippo, Paolo and Malanchini, Giovanni and Vergara, Pasquale and Della Bella, Paolo and Gulletta, Simone and all the Investigators of the study, all the Investigators of the study},
title = {Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study},
journal = {Artificial Organs},
year = {2024},
doi = {10.1111/aor.14708}
}
EUVIMED